Japan-based Maruho Co Ltd has named Atsushi Sugita as its new president and chief executive officer, effective 18 December 2020, it was reported on Friday.
Sugita is to replace Koichi Takagi who will remain with the company as chairman of the board.
Sugita has served at Johnson & Johnson's US headquarters and Janssen Japan. He held various positions at Maruho's R&D Labs, Head Office, and global subsidiaries.
GXO appointed to manage NHS England bowel cancer home testing kits
Samsung Biologics honoured at 2026 CDMO Leadership Awards
Frost & Sullivan names Abzena a market-leading ADC CDMO
Vulcan Two signs five-year ERP licence agreement to support ePharmacy expansion
SportsMed Physical Therapy named Physical Therapy Company of the Year
Ensorcell adds new senior leadership team members
GelMEDIX completes USD13m seed financing, announces first partnership
AmacaThera named Life Sciences Ontario Emerging Company of the Year
GenSight Biologics reports first patient treated in GS010 REVISE study